Free Trial
CVE:KNE

Kane Biotech (KNE) Stock Price, News & Analysis

C$0.13
0.00 (0.00%)
(As of 10:25 AM ET)
Today's Range
C$0.13
C$0.14
50-Day Range
C$0.10
C$0.16
52-Week Range
C$0.05
C$0.17
Volume
70,000 shs
Average Volume
137,145 shs
Market Capitalization
C$17.23 million
P/E Ratio
N/A
Dividend Yield
3.08%
Price Target
N/A
KNE stock logo

About Kane Biotech Stock (CVE:KNE)

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections. It offers revyve, an antimicrobial wound gel; and shampoos, shampoo bars, and scalp detoxifiers under the DermaKB brand. The company is also developing coactiv+ Antimicrobial Surgical Hydrogel for use in surgical/acute wounds; coactiv+ Antimicrobial Wound Rinse for use in acute and chronic wounds; coactiv+ Antimicrobial Wound Gel Spray for use in acute, chronic wounds, and first and second degree burns; and DispersinB Hydrogel for prosthetic joint infection. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.

KNE Stock Price History

KNE Stock News Headlines

Kane Biotech (CVE:KNE) Announces Earnings Results
Kane Biotech (KNE) to Release Quarterly Earnings on Thursday
Kane Biotech to Host Investor Webinar
See More Headlines
Receive KNE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kane Biotech and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/23/2024
Today
5/27/2024
Next Earnings (Estimated)
9/03/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$-4,940,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$2.74 million
Cash Flow
C$0.02 per share
Book Value
C($0.08) per share

Miscellaneous

Free Float
N/A
Market Cap
C$17.23 million
Optionable
Not Optionable
Beta
0.55
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Marc Edwards
    President, CEO & Director
  • Mr. Ray Dupuis
    Chief Financial Officer
  • Mr. Kevin Cole
    President & CEO of STEM Animal Health Inc
  • Mr. Dena Mehraban
    General Manager of STEM Animal Health Inc
  • Dr. Robert B. Huizinga CNeph(C) (Age 58)
    M.Sc., MSc(Epi), Ph.D., R.N., RN NNC, Executive Chairman & Member of Scientific Advisory Board
  • Dr. Gregory S. Schultz Ph.D. (Age 74)
    Chief Scientific Officer & Member of Scientific Advisory Board
  • Lorne Gorber
    Investor Relations
  • Ms. Lori Christofalos
    Vice President of Quality & Compliance
  • Ms. Wendy Nachtigall
    Director of Marketing
  • Nicole Sendey
    Investor Relations Adviser

KNE Stock Analysis - Frequently Asked Questions

How have KNE shares performed in 2024?

Kane Biotech's stock was trading at C$0.08 at the beginning of 2024. Since then, KNE stock has increased by 75.0% and is now trading at C$0.14.
View the best growth stocks for 2024 here
.

When is Kane Biotech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, September 3rd 2024.
View our KNE earnings forecast
.

How were Kane Biotech's earnings last quarter?

Kane Biotech Inc. (CVE:KNE) announced its quarterly earnings results on Thursday, May, 23rd. The company reported ($0.01) earnings per share for the quarter. The company earned $0.05 million during the quarter.

How do I buy shares of Kane Biotech?

Shares of KNE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:KNE) was last updated on 5/27/2024 by MarketBeat.com Staff

From Our Partners